About
Hanmi Pharm Co Ltd (KO:128940) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 13 2026
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Feb 24 2026
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
Jan 28 2026
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
Dec 19 2025
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
Nov 19 2025
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
Financials
Revenue
₩1.46 T
Market Cap
₩6.34 T
Dividend Yield
0.40%